an important research collaboration with Sheba Medical Center in Israel Brigham and Women’s Hospital and Harvard Medical School in Boston
We are excited to announce that CaloSense Health, which is a part of the ARC Innovation at Sheba community at the Sheba Tel HaShomer City of Health, recently established an ambitious collaborative study that involves top medical and academic centers and experts in the fields of bariatric surgery, patient-centered care, patient engagement, health information technology, and innovation.
This project is led by prof. David Goitein, the Head of Bariatric & Metabolic Surgery at Chaim Sheba Medical Center in Israel, and Prof. Ronen Rozenblum, PhD MPH, the founding Director of the Unit for Innovative Healthcare Practice & Technology at Mass General Brigham and Harvard Medical School in Boston.
The aim of the joint project is to examine the impact of our novel artificial intelligence (AI)-based application on patient compliance with the recommended pre- and post-bariatric/metabolic surgery clinical protocol. By using our innovative "Patient-Journey-Platform", better adherence to medical and lifestyle modification recommendations is expected, resulting in enhanced patient satisfaction with the process which will potentially lead to better clinical results.
CaloSense Health, led by Alon Ezra and Nitzan Shenar, provides a "companion" in the form of a remote, multidisciplinary, AI-based virtual clinic solution for patients who undergo bariatric surgery – a life-changing event. Specifically, CaloSense delivers a lifelong patient journey platform, providing a hybrid solution with Remote Patient Monitoring (RPM) coupled with a proactive monitoring team to support patients through the pre & post-bariatric surgery process.
We are absolutely thrilled to have reached this significant milestone!